Nikita (Oral)

Generic name:pitavastatin (oral route) [ pi-tav-a-STAT-in ]
Drug class:Statins

Medically reviewed by Drugs.com. Last updated on May 29, 2022.

Commonly used brand name(s)

In the U.S.

• Livalo
• Nikita
• Zypitamag

Available Dosage Forms:

• Tablet

Therapeutic Class: Antihyperlipidemic

Pharmacologic Class: HMG-COA Reductase Inhibitor

Uses for Nikita

Pitavastatin is used together with a proper diet to lower high cholesterol levels and triglyceride (fat) levels in the blood and increase good cholesterol (HDL) in patients with primary hyperlipidemia or mixed dyslipidemia. This medicine may help prevent medical problems (eg, heart attacks, strokes) that are caused by fat clogging the blood vessels. Livalo® is also used to treat heterozygous familial hypercholesterolemia in children 8 years of age and older.

Pitavastatin belongs to the group of medicines called HMG-CoA reductase inhibitors, or statins. It works to reduce the amount of cholesterol in the blood by blocking an enzyme that is needed to make cholesterol.

This medicine is available only with your doctor's prescription.

Before using Nikita

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of Livalo® in children younger than 8 years of age with heterozygous familial hypercholesterolemia or in children with other types of hyperlipidemia. Safety and efficacy have not been established.

Appropriate studies have not been performed on the relationship of age to the effects of Zypitamag™ in the pediatric population. Safety and efficacy have not been established.

Geriatric

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of pitavastatin in the elderly. However, elderly patients are more sensitive to the effects of Zypitamag tablets than younger adults. Elderly patients are also more likely to have age-related liver, kidney, heart, and muscle problems, which may require caution and an adjustment in the dose for patients receiving Livalo® tablets.

Breastfeeding

Studies in women breastfeeding have demonstrated harmful infant effects. An alternative to this medication should be prescribed or you should stop breastfeeding while using this medic...